On this page
Global oxygen production in 2025 is estimated at over 87.9 million tonnes (gaseous and liquid oxygen equivalent), reflecting a highly mature, large-scale industrial gas market that underpins modern industry, healthcare and energy systems. Supply growth is driven by steelmaking, chemicals, refining, healthcare demand, wastewater treatment and emerging applications such as gasification and clean energy processes.
Market conditions are characterised by capital-intensive production, long-term supply contracts and close integration with customer operations. Pricing is generally stable, influenced by energy costs, plant utilisation rates and logistics rather than commodity-style volatility. Merchant liquid oxygen markets coexist with large volumes of on-site and captive production.
Production leadership remains concentrated in regions with heavy industrial activity, advanced healthcare systems and established industrial gas infrastructure. Asia Pacific leads global volume due to steel and manufacturing output. Europe and North America maintain high installed capacity supporting industry and medical demand. Middle Eastern capacity is closely tied to refining, petrochemicals and metals. Many smaller or developing regions remain dependent on merchant supply or imports of liquid oxygen.
Industrial and medical applications continue to support steady baseline demand growth. Buyers value reliability, safety performance, uninterrupted supply and proximity of production to consumption sites.
Industrial oxygen dominates global volume demand, while medical and specialty oxygen command higher margins due to purity, compliance and delivery requirements. Buyers prioritise purity standards, uninterrupted supply and regulatory certification.
Cryogenic ASUs dominate global production due to scale and purity capability. PSA and VSA systems support decentralised and smaller-volume demand. Buyers benefit from predictable output, long asset life and integration with core operations.
Industrial applications dominate total volume, while healthcare represents critical, non-substitutable demand. Buyers focus on uptime, safety performance and regulatory alignment.
Asia Pacific leads oxygen production driven by steelmaking, manufacturing and urban healthcare demand, supported by large installed ASU capacity.
Europe maintains advanced oxygen infrastructure aligned with metals, chemicals and stringent healthcare standards, with stable long-term demand.
North America supports diversified oxygen demand across industry, healthcare and environmental services, with extensive on-site production.
Capacity is closely linked to refining, petrochemicals and metals, often through large captive ASUs integrated with industrial complexes.
These regions rely more on merchant oxygen supply, with growth tied to infrastructure development, healthcare expansion and industrialisation.
Oxygen supply begins with air intake and separation, followed by compression, liquefaction, storage and distribution via pipelines, tankers or cylinders. Downstream buyers include steel mills, chemical plants, hospitals, utilities and manufacturers.
Electricity cost, plant utilisation and logistics dominate the cost structure. Pipeline supply and on-site production minimise transport cost, while merchant liquid oxygen serves distributed demand. Cross-border trade is limited due to transport economics, making oxygen a predominantly local or regional market.
The oxygen ecosystem includes industrial gas producers, equipment manufacturers, healthcare providers, heavy industry, utilities and regulators. Market leaders focus on asset reliability, safety excellence and long-term customer integration.
Equipment suppliers support ASUs, compressors, storage tanks, pipelines and monitoring systems. Commercial models emphasise long-term contracts, bundled gas supply and operational services.
Explore Energy and Environmental Chemicals Insights
View Reports
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.